Related Experiment Videos
[Subpartal tocolysis in fetal distress situations]
Zeitschrift Fur Geburtshilfe Und Perinatologie
|October 1, 1982
Summary
Fenoterol effectively manages intrapartum fetal distress by suppressing labor and improving fetal condition, reducing the need for emergency operations. This beta-adrenergic receptor stimulator offers a valuable therapeutic option for high-risk pregnancies.
Area of Science:
- Obstetrics and Gynecology
- Perinatology
- Pharmacology
Context:
- Intrapartum fetal distress poses significant risks to both mother and neonate.
- Conventional treatments may not always prevent adverse outcomes.
- Cardiotocography (CTG) and fetal scalp blood measurements are key diagnostic tools.
Purpose:
- To evaluate the efficacy of fenoterol, a beta-adrenergic receptor stimulator, in managing intrapartum fetal distress.
- To assess the impact of fenoterol on labor suppression and fetal well-being.
- To determine the rate of avoidance of emergency operative interventions.
Summary:
- A study involving 43 patients with intrapartum fetal distress (31-42 weeks gestation) investigated the use of fenoterol.
- Fenoterol was administered via intravenous bolus and/or infusion.
- Labor suppression was achieved in 88% of cases, and emergency operations were avoided in 84%.
Impact:
- Fenoterol demonstrated significant success in improving fetal condition and preventing emergency Cesarean sections.
- Fetal blood gas analysis showed improvements post-fenoterol therapy.
- High Apgar scores at 1 and 5 minutes indicate positive neonatal outcomes.